Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction
The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced ...
Evaxion Biotech: Evaxion launches improved AI-Immunology platform for vaccine antigen prediction
The new version 5.0 of the AI model EDEN features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction featureThe launch will expectedly impro ...
EurekAlert!8d
World’s top organic chemists to assemble in Paris for inaugural symposium
Rice Unviersity's Global Paris Center will host the Art and Science of Total Synthesis of Natural and Designed Molecules for Biology and Medicine symposium ... for leaders and practitioners in ...
23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial
ME-01473 inhibited tumor growth in a patient-derived xenograft mouse model of non-small cell lung cancer Elevated levels of ...
Cellworks Biosimulation Combined with Tumor Microenvironment Modeling Enhances Predictions of IO Response in NSCLC Patients
Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced results from a study using Cellworks computational biosimulation to predict how ...
Le Lézard1d
Kyverna Therapeutics Presents Patient Data Reinforcing Potential of KYV-101 for Treatment of Neuroinflammatory Diseases in Symposium at ECTRIMS 2024
Company symposium to highlight case reports from 11 patients with stiff-person syndrome, myasthenia gravis and multiple sclerosis reinforcing KYV-101's initial efficacy and safety profile and broad ...
Cellworks Group Inc.: Cellworks Biosimulation Predicts PARPi Benefit in Patients with Ovarian, Pancreatic, Prostate and Triple-Negative Breast Cancers
Personalized Therapy Biosimulation Study Identifies Homologous Recombination Deficiency in Cancer Patients Beyond BRCA Status Cellworks Group Inc., a leader in Personalized Therapy Decision Support ...
Health News Florida3d
Twenty-seven faculty members recognized with Outstanding Research Achievement Awards
USF faculty continually demonstrate their skills in conducting high-impact research and innovation to advance frontiers of ...
Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity
NDAQ:SRRK) Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity ...
The Gustavian Weekly6d
The Fall Research Symposium returns
Research Symposium will be held from 3:30 p.m. to 5:00 p.m. on Wednesday, Sept. 18th in Beck Hall. Sophomores to Seniors from various disciplines at Gustavus will ...
Le Lézard7d
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced that researchers will present two posters on the ongoing phase 2 trial (NCT04752813) of BPGbio lead ...
Paris15d
Fête de la Science 2024: things to do in Seine-Saint-Denis (93)
Mission Matilda: Plural identities in research October 10 Mission Matilda is a project co-created by Diagonale Université Paris-Saclay and École Estienne, and produced by students in the DSAA Design ...